Results 31 to 40 of about 1,315,331 (224)

Occlusion of Bilobulated Left Atrial Appendage Using the Dual-Watchman Technique: A Long-Term Follow-Up Study

Frontiers in Cardiovascular Medicine, 2022
BackgroundPercutaneous left atrial appendage (LAA) occlusion has been considered an efficient alternative to oral anticoagulation to prevent embolic events in patients with non-valvular atrial fibrillation (NVAF).
Tao Chen, Qing-song Wang, Ge Liu, Xu Lu, Ting-ting Song, Ming-yuan Shi, Hang Zhu, Yang Mu, Jun Guo, Yun-dai Chen   +9 more
doaj   +1 more source

Impact of conscious sedation and general anesthesia on periprocedural outcomes in Watchman left atrial appendage closure

Cardiology Journal, 2021
BACKGROUND: Transcatheter left atrial appendage closure (LAAC) is performed either in conscious sedation (CS) or general anesthesia (GA), and limited data exist regarding clinical outcomes for the two approaches.
Caroline Kleinecke, Wasim Allakkis, Eric Buffle, Xiao-Xia Liu, Yamen Mohrez, Steffen Gloekler, Johannes Brachmann, Steffen Schnupp, Stephan Achenbach, Jiangtao Yu   +9 more
doaj   +1 more source

Two‐Year Outcomes With a Next‐Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The PINNACLE FLX (Protection Against Embolism for Non‐valvular AF [Atrial Fibrillation] Patients: Investigational Device Evaluation of the Watchman FLX LAA [Left Atrial Appendage] Closure Technology) trial evaluated the safety and efficacy of ...
Shephal K. Doshi, Saibal Kar, Ashish Sadhu, Rodney Horton, Jose Osorio, Christopher Ellis, James Stone, Manish Shah, Srinivas R. Dukkipati, Stuart Adler, Devi G. Nair, Jamie Kim, Oussama Wazni, Matthew J. Price, David R. Holmes, Robert Shipley, Thomas Christen, Dominic J. Allocco, Vivek Y. Reddy   +18 more
doaj   +1 more source

The WATCHMAN device and post-implantation anticoagulation management. A review of key studies and the risk of device-related thrombosis. [PDF]

Am J Cardiovasc Dis, 2021
Background: Ischemic stroke is a devastating complication of atrial fibrillation (Afib). Anticoagulation is the gold standard to prevent stroke and systemic embolization. However, many patients have a contraindication to oral anticoagulation.
Magdi M, Renjithal SLM, Mubasher M, Mostafa MR, Lathwal Y, Mukuntharaj P, Mohamed S, Alweis R, Tan BE, Baibhav B.   +9 more
europepmc   +1 more source

Infection Rate and Outcomes of Watchman Devices: Results from a Single-Center 14-Year Experience

Biomedicine Hub, 2021
The Watchman device (WD) is a commonly used alternative strategy to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation who have an increased bleeding risk. There are rare case reports of WD-related infection.
Robert C. Ward, Trevon McGill, Fadi Adel, Shiva Ponamgi, Samuel J. Asirvatham, Larry M. Baddour, David R. Holmes Jr., Daniel C. DeSimone, Christopher V. DeSimone   +8 more
doaj   +1 more source

Life through a Lens

, 2020
Anonymised interview transcripts and nvivo analysis. As numbers of people with an intellectual disability and dementia increase globally, strategies and interventions to reduce stress or agitation are sought.
Watchman, Karen
core   +1 more source

Non-pharmacologic approach to prevent embolization in patients with atrial fibrillation in whom anticoagulation is contraindicated

Clinics and Practice, 2017
Ischemic stroke is the most common complication of atrial fibrillation (AF). Anticoagulation therapy reduces the risk of systemic embolization in almost all patients with AF irrespective of the type of AF (paroxysmal, persistent or permanent).
Munish Sharma, Koroush Khalighi
doaj   +1 more source

Long-term outcomes of percutaneous left atrial appendage closure for the prevention of stroke in patients with atrial fibrillation: Asia-Pacific experience

Journal of the Formosan Medical Association, 2022
Background/Purpose: In patients with non-valvular atrial fibrillation (NVAF), the left atrial appendage occluder (LAAO) is an alternative treatment for stroke prevention. However, the long-term outcomes in Asia was generally unknown. Methods and Results:
Fu-Chun Chiu, Pang-Shuo Huang, Jien-Jiun Chen, Juey-Jen Hwang, Chia-Ti Tsai   +4 more
doaj   +1 more source

Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: The Watchman Device versus Warfarin [PDF]

, 2022
Atrial fibrillation is a common heart arrhythmia that leads to an increased risk of stroke. Warfarin was the original anticoagulant that would be used as the treatment for atrial fibrillation.
Delaney, Emma
core   +1 more source

Debate: Percutaneous left atrial appendage closure. The clinical cardiology perspective

REC: Interventional Cardiology (English Ed.), 2021
QUESTION: Briefly, what is the evidence behind the percutaneous left atrial appendage closure (LAAC) regarding oral anticoagulation (OA)? Is there any evidence on direct-acting oral anticoagulants (DAOAs)?
Tomás Benito-González
doaj   +1 more source